InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the full record of transactions filed by Ben Yong. Insider active across 2 companies, notably Corbus Pharmaceuticals Holdings, Inc.. Cumulatively, 5 disclosures have been published. History available since 30 May 2024. The latest transaction was filed on 1 July 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Ben Yong is a declarant linked to Corbus Pharmaceuticals Holdings, Inc., where he is Director, and to BridgeBio Oncology Therapeutics, Inc., where he is Chief Med & Dev Officer. He has 5 filings in total, and across the 5 recent filings observed, the period runs from 2024-06-03 to 2026-07-06, with the transaction nature shown as Attribution.